Harmony Biosciences Holdings, Inc. ( HRMY) - Stock Earnings
HRMY Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 50.9 million USD | 239.5 million USD |
| 2025Q4 | 22.5 million USD | 243.8 million USD |
| 2026Q1 | 32.5 million USD | 215.4 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
HRMY Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 128.9 million USD | 582.0 million USD |
| 2024 | 145.5 million USD | 714.7 million USD |
| 2025 | 158.7 million USD | 868.5 million USD |
| 2026 Est. | — | — |
HRMY
Price: $34.18
52 week price:
Payout Ratio Range:
Earnings Per Share: 2.48 USD
P/E Ratio: 12.16
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 87588
Market Capitalization: 1.9 billion